Home
  • Home
  • About Us
    • Overview
      • History
      • Experience
    • People
    • Career
  • What We Do
    • Medical Coating Platform
      • Coatings
      • Tech-Transfer
      • Professional Services
      • SilverCoat™ - Antimicrobial Silicone Foley Catheter
    • Advanced Wound Care Products
      • ColActive® Plus Ag
      • CovaStat™ - BioActive Absorbable Hemostatic Sponge
      • CovaSorb™ - BioActive Absorbent Foam Replacement Dressing
    • Antimicrobial Silicone Dressings
      • IV Clear™ Antimicrobial Clear Silicone IV Dressing
      • SurgiClear™ Antimicrobial Clear Silicone Surgical Dressing
    • Covalon's Markets
  • Who We Work With
    • Medical Device Companies
    • Medical Distributors
      • Sales/Orders Page - Coming Soon
    • International
  • What's New
    • Medical Brief
      • Archive
    • Medical Brief Newsletter Sign Up
    • Covalon Will Be at...
      • Meet with a Covalon Representative
  • Investor Relations
    • Press Releases
      • 2013
      • 2012
      • 2011
    • Executive Management
    • Board of Directors
    • Corporate Governance
    • Financial Results and MD&As
      • 2011 - 2012
      • 2010 - 2011
      • 2009 - 2010
      • 2008 - 2009
      • 2007 - 2008
    • Legal Notices
  • Contact Us
  • Consolidated Financial Statements For the years ended September 30, 2010 and 2009
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three month period ended December 31, 2009
  • Consolidated Financial Statements For the period ended December 31, 2009
  • Management’s Discussion and Analysis of Financial Condition and Results of Operations September 30, 2010
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three and six month periods ended March 31, 2010
  • Covalon Technologies Ltd. Consolidated Financial Statements For the period ended March 31, 2010
  • Consolidated Financial Statements For the period ended June 30, 2010
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three and nine month periods ended June 30, 2010
  • Consolidated Financial Statements For the years ended September 30, 2009 and 2008
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the year ended September 30, 2009
  • Consolidated Financial Statements For the period ended March 31, 2009
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three and six-month periods ended March 31, 2009
  • Consolidated Financial Statements For the period ended June 30, 2009
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three and nine-month periods ended June 30, 2009
  • MANAGEMENT’S DISCUSSION & ANALYSIS For the three month period ended December 31, 2008
  • Consolidated Financial Statements For the period ended December 31, 2008
Sign up for our Medical
Brief Newsletter

Latest News

Jun 14, 2013

Covalon Announces Results of Annual and Special Meeting of Shareholders
Read More

May 30, 2013

Covalon Announces Second Quarter Financial Results
Read More

May 16, 2013

Covalon Proposes Share Consolidation
Read More

May 15, 2013

Arab Health Magazine features SurgiClear article: The importance of wound dressings.
Read More

May 01, 2013

Covalon’s ColActive Plus Receives Medicare Billing Codes in Advance of the Symposium on Advanced Wound Care in Denver
Read More
View Archive
Connect with Covalon
  • Legal Notices
  • |
  • Careers
  • |
  • Sitemap
  • |
  • Contact Us
  • Linkedin
  • LinkedinShare
  • Youtube
  • Twitter
Covalon is an ISO 13485:2003 registered company. Covalon Technologies Ltd. Copyright 2013
Toronto Web Design by LinxSmart